LFVN director granted 13,531 shares; now holds 64,879
LifeVantage (LFVN) reported a routine insider equity grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LifeVantage (LFVN) reported a routine insider equity grant. Director Cynthia Latham acquired 13,531 shares of common stock on 11/06/2025 under the company’s outside director compensation program. The grant vests in a single installment on November 6, 2026, contingent on continuous service. The reported price of $7.76 reflects the weighted average closing price over the ten trading days preceding the grant date. Following this grant, her beneficial ownership stands at 64,879 shares, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 13,531 | $7.76 | $105K |
Footnotes (2)
- F1. These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 6, 2026, subject to the reporting person's continuous service to the issuer through such date.
- F2. The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did LFVN disclose in this Form 4?
What is the reported price for the LFVN grant?
What are the vesting terms for the LFVN director grant?
Who is the reporting person in the LFVN Form 4?
Is this LFVN transaction under Rule 10b5-1?
AI-generated analysis. How Rhea-AI works. Not financial advice.